Evidence map›Paper›PMID 40052822›Full record

ArticleNucleic acids research2025

Mono-ubiquitination of TopBP1 by PHRF1 enhances ATR activation and genomic stability.

Fei Zhao, Chenghui Cai, Huanyao Gao, Jaeyoung Moon, Grania Christyani, Sisi Qin, Yalan Hao, Tongzheng Liu, Zhenkun Lou, Wootae Kim

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fei ZhaoCollege of Biology, Hunan University, Changsha 410082, China.
Chenghui CaiCollege of Biology, Hunan University, Changsha 410082, China.
Huanyao GaoDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, United States.
Jaeyoung MoonDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan 31151 Chungcheongnam-do, Republic of Korea.
Grania ChristyaniDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan 31151 Chungcheongnam-do, Republic of Korea.
Sisi QinDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan 31151 Chungcheongnam-do, Republic of Korea.
Yalan HaoAnalytical Instrumentation Center, Hunan University, Changsha 410082, China.
Tongzheng LiuCollege of Pharmacy/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.
Zhenkun LouDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, United States.ORCID 0000-0003-1938-3091
Wootae KimDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan 31151 Chungcheongnam-do, Republic of Korea.ORCID 0000-0003-4364-3260

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Mayo FoundationMinistry of Science and ICTNational Natural Science Foundation of China 32370779National Research Foundation of Korea 2022R1A2C1091563National Research Foundation of Korea RS-2023-00218261NCI NIH HHS P30 CA015083Provincial Natural Science Foundation of Hunan 2024JJ3008Soonchunhyang University Research Fund
6 · The paper itself

Abstract

The TopBP1-ATR axis is critical for maintaining genomic stability during DNA replication stress, yet the precise regulation of TopBP1 in replication stress responses remains poorly understood. In this study, we identified PHD and Ring Finger Domains 1 (PHRF1) as an important ATR activator through its interaction with TopBP1. Our analysis revealed a correlation between PHRF1 and genomic stability in cancer patients. Mechanistically, PHRF1 is recruited to DNA lesions in a manner dependent on its PHD domain and histone methylation. Subsequently, PHRF1 mono-ubiquitinates TopBP1 at lysine 73, which enhances the TopBP1-ATR interaction and activates ATR. Depletion of PHRF1 disrupts ATR activation and sensitizes cells to replication stress-inducing agents. Furthermore, conditional knockout of Phrf1 in mice leads to early lethality and impaired ATR-Chk1 axis signaling. Collectively, our findings establish PHRF1 as a novel E3 ligase for TopBP1, coordinating the replication stress response by enhancing TopBP1-ATR signaling.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCarrier ProteinsDNA-Binding ProteinsGenomic InstabilityNuclear ProteinsUbiquitin-Protein LigasesAnimalsCell Line, TumorCheckpoint Kinase 1DNA DamageDNA ReplicationHEK293 CellsHistonesHumansMiceMice, KnockoutAtaxia Telangiectasia Mutated ProteinsATR protein, humanCarrier ProteinsCheckpoint Kinase 1CHEK1 protein, humanDNA-Binding ProteinsHistonesNuclear ProteinsTOPBP1 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID40052822
PMCPMC11886831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.